Cambridge Healthtech Institute's Inaugural

Immuno-Oncology Investing & Partnering Forum

(암면역 분야의 투자와 제휴에 관한 포럼)

Facilitating Partnering, Funding & Investment to Advance Immuno-Oncology Drugs

2018년 8월 30일

Cambridge Healthtech Institute is pleased to announce the Inaugural Immuno-Oncology Investing & Partnering Forum to run as part of the Immuno-Oncology Summit in Boston on August 30, 2018. This timely and focused event brings together early- and late-stage investors with fundraising CEOs and research entrepreneurs to encourage partnering and investment, and to ultimately accelerate immune-oncology therapies to market. This Forum will provide ample opportunity for both investors and CEOs to interact through pre-scheduled 1-1 meetings, as well as interactive panels presented by pharma business development and the VC/investment community. Both late-stage and emerging tech companies will present on the agenda.

Cover will include, but is not limited to:

  • Pharmaceuticals
  • Biotechnology
  • Venture Capital Firms
  • Angel Investors
  • Young Companies
  • Emerging Companies

* 주최측 사정에 따라 사전 예고없이 프로그램이 변경될 수 있습니다.

Choose your language
Traditional Chinese
Simplified Chinese

메일링 서비스
메일링 서비스